Skip to main content

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties.

Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes.

Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outcomes to change after periods of time, requiring further adjustments.

Side effects of these drugs can also cause their own challenges. Many antipsychotic drugs cause tremor or shaking, slowed thinking, sexual dysfunction, fatigue or drowsiness, and weight gain. Such unpleasant or disruptive side effects can also make it difficult for those being treated to be consistent in their dose. It’s not unusual for patients to feel frustrated with side effects or other aspects of their treatment, and they can be eager to get off medication as a result.

Additionally, the positive effects of these drugs can lead patients to feel that they are well enough to discontinue their treatment, which then results in relapses and setbacks, the consequences of which can be quite serious. Without adequate support and treatment resources, psychiatric ailments can be as debilitating as any physical disease.

This is why researchers are working hard to find antipsychotic treatment options that lack severe side effects and provide a better level of manageability. Better antipsychotic medications could ensure that patients are not eager to make changes or abandon their treatment programs. Fortunately, scientists are now finding that cannabidiol’s unique properties may provide a stepping stone to an effective, low-risk antipsychotic treatment option.

Cannabidiol has been tested in studies that examine its pharmacological effects in subjects exhibiting psychotic-like symptoms. One study found that CBD was able to regulate neurotransmitters in a way that was similar to some atypical antipsychotic drugs.

Though many more studies and clinical tests will be needed to confirm the reliability of potential CBD antipsychotic treatments, its notable safety profile may make it optimal for patients who struggle with current pharmaceutical options.

It’s certainly not appropriate to say psychosis is an answer to the question of what can CBD cure, but early findings show a great deal of promise. Perhaps CBD can benefit some of the most difficult conditions people can live with.

Manic episodes, severe mood swings, hallucinations, and paranoia can be as debilitating as any chronic physical illness. If CBD can actually reduce and inhibit these symptoms, without the major side effects of conventional drugs, it could be a groundbreaking development in mental health treatments.

Hopefully, studies will progress and we’ll soon know with better certainty what CBD can do for the treatment of these serious psychiatric conditions.

Original Article Source: https://blog.puredosage.com/what-is-cbd/development-of-safer-antipsychotic-medications

Comments

Post a Comment

Popular posts from this blog

Feds Hire Hazmat Firm For Marijuana Eradication Training

An ambitious campaign to decriminalize psychedelics in Washington, D.C., is one step closer to placing their measure on the November ballot with the formal submission of tens of thousands of voter signatures. Organizers have been scrambling for weeks to collect enough signatures from D.C. voters by Monday’s deadline amid historically difficult circumstances: a global pandemic, months of stay-at-home orders and protests over racism and police violence that filled the streets of the nation’s capital. But with the help of innovative signature-gathering techniques and allies flown in from across the country, advocates said they had successfully submitted upwards of 35,000 signatures—more than enough to qualify the initiative. If approved by voters, Initiative 81 would make enforcement of laws against plant- and fungus-based psychedelics among the “lowest law enforcement priorities” for the Metropolitan Police Department. It would not, however, legalize or reduce penalties for the substa...
Post a Comment
Read more

FDA Warns 15 Companies For Illegally Selling CBD Products

The agency also released a consumer update about CBD , the non-psychoactive ingredient in marijuana increasingly used to treat pain and anxiety. Until it learns more about the effectiveness and safety of CBD, the FDA said it cannot generally recognize the ingredient as safe or approve products that contain it. “We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe, or that trying CBD ‘can’t hurt,‘” FDA Principal Deputy Commissioner Amy Abernethy said. The FDA sent letters to the following 15 companies for selling CBD products that violate the Food, Drug and Cosmetic Act, for marketing the products to treat illnesses or for therapeutic use, claiming it’s a dietary supplement or adding it to food for humans and animals. -Red Pill Medical Inc. of Phoenix, Arizona -Pink Collections Inc. of Beverly Hills, California -Healthy Hemp Strategies LLC (does ...
Post a Comment
Read more